Navigation Links
Hormone Therapy Could Increase Ones Risk For Breast Cancer

More evidence shows that taking hormone therapy could increase ones risk for breast cancer. A recent study shows postmenopausal women // who took estrogen-plus-progestin hormone therapy for one year experienced a two-fold increase in breast density -- a risk factor for cancer. The women's risk of having an abnormal mammogram was four-times greater, as well.

Researchers studied 413 postmenopausal women between ages 50 and 79. The average woman was 62 years old and 12-years post-menopausal. Half of the women received estrogen plus progestin, and the other half received a placebo. All had a baseline mammogram at the beginning of the study and a follow-up mammogram one or two years later.

The effect of hormone replacement therapy was especially high in the oldest age bracket. Women between ages 70 and 79 experienced a nearly three-fold increase in breast density compared to younger women, presumably because their breast tissue was less dense to begin with.

Researchers say these findings are unique in showing a sustained effect over two years and that even in older postmenopausal women, breast density can increase in response to estrogen-plus-progestin therapy. Breast density was measured with a computer-aided technique that calculated the amount of dense, or white-appearing, tissue on digitized mammography images. Denser breast tissue increases a woman's risk for cancer, but makes the cancer more difficult to diagnose because both dense tissue and cancer appear white on a mammography.

In conclusion researchers say their results suggest that avoiding such hormone therapy may help improve the sensitivity of mammograms for detecting early breast cancers at a stage when they are most treatable.
'"/>




Page: 1

Related medicine news :

1. Levothyroxine Thyroid Hormone Replacement, Approved for Hypothyroidism
2. Hormone replacement Therapy a headache
3. Ovarian cancer in relationship with Hormone therapy
4. Hormone contraceptives lead to bone problems
5. Hormone treatment helps obese people slim down
6. Hormone Deficiency Results In Miscarriage
7. Hormones Linked To Migraines
8. Hormone replacement therapy helps women
9. Decrease of Hunger Hormone after Obesity Surgery
10. Possible benefits of Hormone Replacement Therapy
11. Hormone replacement therapy improves sexual function
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... Pa. (PRWEB) , ... December 08, 2016 , ... ... Medicine Southern Chester County, a Property owned by an affiliate of Seavest, has ... square foot Penn Medicine Southern Chester County ambulatory care center (ACC) was named ...
(Date:12/8/2016)... ... ... With the increasing demand for dental implants, the National Association of Dental ... dentists and patients about the safety issues related to dental restorations. According to the ... is projected to reach $6.4 billion in 2018 with more than 30 million Americans ...
(Date:12/8/2016)... Tampa, Fla (PRWEB) , ... December 08, 2016 ... ... offering smarter modes of access for customers and employees that are both engaging ... ChangeGear 7 with Service Smart Technology, the software company revealed today its plans ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... has been recognized for adherence to the highest standards of trauma, maternity, cancer ... announced the center's president and CEO, Dr. Daniel Messina. , Among the recognitions, ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s ... possible. With this in mind, SIGVARIS has created a new line of anti-embolism ... bed rest and provide the benefits of graduated compression when transitioning from recovery ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... KEY FINDINGS North America ... market in 2016 and is expected to continue in ... a large number of surgical procedures that are taking ... in the patient temperature management market.) Patient warming and ... of blood during surgeries, lowering the risks of neurological ...
(Date:12/8/2016)... INDIANAPOLIS , Dec. 8, 2016  Eli Lilly ... detailed results of its phase 3 EXPEDITION3 trial at ... (CTAD) meeting. As previously disclosed, solanezumab did not meet ... study of solanezumab initiated in people with mild dementia ... pursue regulatory submissions for solanezumab for the treatment of ...
(Date:12/8/2016)... , 8 de dezembro de 2016  A Mederi Therapeutics Inc . ... um tratamento não cirúrgico para a doença do refluxo gastroesofágico (DRGE). ... ... Live Stretta procedure performed and broadcast during ... at Wuhan Union Hospital ...
Breaking Medicine Technology: